These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9392 related articles for article (PubMed ID: 18975677)

  • 21. COMS eye plaque brachytherapy dosimetric sensitivity to source photon energy and seed design.
    Gagne NL; Rivard MJ
    Appl Radiat Isot; 2013 Sep; 79():62-6. PubMed ID: 23728350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneous dose calculations for Collaborative Ocular Melanoma Study eye plaques using actual seed configurations and Task Group Report 43 formalism.
    Deufel CL; Furutani KM
    Brachytherapy; 2015; 14(2):209-30. PubMed ID: 25533415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantifying the dosimetric influences of radiation coverage and brachytherapy implant placement uncertainty on eye plaque size selection.
    Gagne NL; Rivard MJ
    Brachytherapy; 2013; 12(5):508-20. PubMed ID: 23466357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radio-luminescent imaging for rapid, high-resolution eye plaque loading verification.
    Yan H; De Jean P; Grafil E; Ashraf R; Niedermayr T; Astrahan M; Mruthyunjaya P; Beadle B; Xing L; Liu W
    Med Phys; 2023 Jan; 50(1):142-151. PubMed ID: 36183146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ROPES eye plaque brachytherapy dosimetry for two models of (103)Pd seeds.
    Saidi P; Sadeghi M; Shirazi A; Tenreiro C
    Australas Phys Eng Sci Med; 2011 Jun; 34(2):223-31. PubMed ID: 21452056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optic disc dose reduction in ocular brachytherapy using
    Lee YC; Lin SC; Kim Y
    J Appl Clin Med Phys; 2020 Sep; 21(9):57-70. PubMed ID: 32656945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comprehensive dosimetric comparison between (131)Cs and (125)I brachytherapy sources for COMS eye plaque implant.
    Zhang H; Martin D; Chiu-Tsao ST; Meigooni A; Thomadsen BR
    Brachytherapy; 2010; 9(4):362-72. PubMed ID: 20116342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosimetry for 125I seed (model 6711) in eye plaques.
    Chiu-Tsao ST; Anderson LL; O'Brien K; Stabile L; Liu JC
    Med Phys; 1993; 20(2 Pt 1):383-9. PubMed ID: 8497229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to design, fabricate, and validate a customized COMS-style eye plaque: Illustrated with a narrow-slotted plaque example.
    Deufel CL; Dalvin LA; Qian J; Vaishnav B; Cutsinger JM; Wittich MN; Petersen IA
    Brachytherapy; 2021; 20(6):1235-1244. PubMed ID: 34217602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiobiology for eye plaque brachytherapy and evaluation of implant duration and radionuclide choice using an objective function.
    Gagne NL; Leonard KL; Rivard MJ
    Med Phys; 2012 Jun; 39(6):3332-42. PubMed ID: 22755715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosimetric study of the 15 mm ROPES eye plaque.
    Granero D; Pérez-Calatayud J; Ballester F; Casal E; de Frutos JM
    Med Phys; 2004 Dec; 31(12):3330-6. PubMed ID: 15651616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental measurements and Monte Carlo calculations for (103)Pd dosimetry of the 12 mm COMS eye plaque.
    Saidi P; Sadeghi M; Tenreiro C
    Phys Med; 2013 May; 29(3):286-94. PubMed ID: 22592132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BrachyView: proof-of-principle of a novel in-body gamma camera for low dose-rate prostate brachytherapy.
    Petasecca M; Loo KJ; Safavi-Naeini M; Han Z; Metcalfe PE; Meikle S; Pospisil S; Jakubek J; Bucci JA; Zaider M; Lerch ML; Qi Y; Rosenfeld AB
    Med Phys; 2013 Apr; 40(4):041709. PubMed ID: 23556879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update of the CLRP eye plaque brachytherapy database for photon-emitting sources.
    Safigholi H; Parsons Z; Deering SG; Thomson RM
    Med Phys; 2021 Jun; 48(6):3373-3283. PubMed ID: 33735471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seed localization in eye plaque brachytherapy.
    Emery RS; Szechter A
    Med Phys; 1998 Aug; 25(8):1491-2. PubMed ID: 9725139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seed coordinates of a new COMS-like 24 mm plaque verified using the FARO Edge.
    McCauley Cutsinger SE; Furutani KM; Forsman RM; Corner SM
    J Appl Clin Med Phys; 2015 Nov; 16(6):293-301. PubMed ID: 26699584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosimetric benefit of a new ophthalmic radiation plaque.
    Marwaha G; Wilkinson A; Bena J; Macklis R; Singh AD
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1226-30. PubMed ID: 22658440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and optimizing a novel ocular plaque brachytherapy with dual-core of
    Sharifzadeh M; Chiniforoush TA; Sadeghi M
    Phys Med; 2021 Nov; 91():99-104. PubMed ID: 34742099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BEDVH-A method for evaluating biologically effective dose volume histograms: application to eye plaque brachytherapy implants.
    Gagne NL; Leonard KL; Huber KE; Mignano JE; Duker JS; Laver NV; Rivard MJ
    Med Phys; 2012 Feb; 39(2):976-83. PubMed ID: 22320806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the importance of quality assurance (QA) for COMS eye plaque Silastic inserts: A guide to measurement methods, typical variations, and an example of how QA intercepted a manufacturing aberration.
    Oare CC; Deufel CL; McCauley Cutsinger J; De La Fuente Herman T; Ferreira C
    J Appl Clin Med Phys; 2021 Aug; 22(8):72-82. PubMed ID: 34231949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 470.